ArticleLiver cancer2022

Evolution of Survival Impact of Molecular Target Agents in Patients with Advanced Hepatocellular Carcinoma.

Kazufumi Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.